| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA1814392
Max Phase: Preclinical
Molecular Formula: C18H17FN2O5S
Molecular Weight: 392.41
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CCOC1Oc2ccc(F)cc2C(=O)/C1=C\Nc1ccc(S(N)(=O)=O)cc1
Standard InChI: InChI=1S/C18H17FN2O5S/c1-2-25-18-15(17(22)14-9-11(19)3-8-16(14)26-18)10-21-12-4-6-13(7-5-12)27(20,23)24/h3-10,18,21H,2H2,1H3,(H2,20,23,24)/b15-10+
Standard InChI Key: GMAPJYNXPOYDQD-XNTDXEJSSA-N
Associated Targets(Human)
5'-nucleotidase 622 Activities
Associated Targets(non-human)
Alkaline phosphatase, tissue-nonspecific isozyme 128 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Intestinal alkaline phosphatase 300 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
5'-nucleotidase 305 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 392.41 | Molecular Weight (Monoisotopic): 392.0842 | AlogP: 2.41 | #Rotatable Bonds: 5 |
| Polar Surface Area: 107.72 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 2 |
| #RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 10.82 | CX Basic pKa: | CX LogP: 1.99 | CX LogD: 1.99 |
| Aromatic Rings: 2 | Heavy Atoms: 27 | QED Weighted: 0.76 | Np Likeness Score: -0.82 |
References
| 1. al-Rashida M, Ashraf M, Hussain B, Nagra SA, Abbas G.. (2011) Discovery of new chromone containing sulfonamides as potent inhibitors of bovine cytosolic carbonic anhydrase., 19 (11): [PMID:21555223] [10.1016/j.bmc.2011.04.040] |
| 2. al-Rashida M, Raza R, Abbas G, Shah MS, Kostakis GE, Lecka J, Sévigny J, Muddassar M, Papatriantafyllopoulou C, Iqbal J.. (2013) Identification of novel chromone based sulfonamides as highly potent and selective inhibitors of alkaline phosphatases., 66 [PMID:23831808] [10.1016/j.ejmech.2013.06.015] |
| 3. al-Rashida M, Batool G, Sattar A, Ejaz SA, Khan S, Lecka J, Sévigny J, Hameed A, Iqbal J.. (2016) 2-Alkoxy-3-(sulfonylarylaminomethylene)-chroman-4-ones as potent and selective inhibitors of ectonucleotidases., 115 [PMID:27054295] [10.1016/j.ejmech.2016.02.073] |
Source
Source(1):